Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neurofibromatosis 1 2Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Glioblastoma 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Attention Deficit Disorder with Hyperactivity 1Acute Kidney Injury 1

Interventions

daratumumab 2Renal Replacement Therapy 1Plasma Exchange 1Ischemic Preconditioning 1Cilastatin 1Antibiotic Prophylaxis 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acute Kidney Injury × Acetylcysteine × 1 year × Clear all
NCT07156786 2025-09-19

N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial

Fakultas Kedokteran Universitas Indonesia

Phase 2/3 Not yet recruiting
72 enrolled
Genitourinary

Neoplasms, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡